Literature DB >> 25648670

Emergence of oxacillin-resistant Staphylococcus lugdunensis carrying staphylococcal cassette chromosome mec type V in central Taiwan.

Ting-Yu Yen1, Yun-Ju Sung2, Hsiao-Chuan Lin1, Ching-Tien Peng1, Ni Tien2, Kao-Pin Hwang1, Jang-Jih Lu3.   

Abstract

BACKGROUND: Staphylococcus lugdunensis has emerged as a key pathogen for clinical infection. It is sensitive to most antistaphylococcal agents, but it is increasingly resistant to β-lactam antibiotics. Oxacillin-resistant S. lugdunensis isolates carrying the mecA gene pose a major concern for therapy failure.
METHODS: To assess the epidemiology and presence of mecA in S. lugdunensis, we gauged the prevalence and antibiotic resistance of S. lugdunensis in clinical specimens by using multiplex polymerase chain reaction (PCR) and pulsed-field gel electrophoresis.
RESULTS: Thirty S. lugdunensis isolates were collected and examined between October 2009 and December 2010. The resistance to penicillin (87%) and oxacillin (20%) was noted. All oxacillin-resistant isolates (6/30) had type V or VT SCCmec. Most (67%, 4/6) isolates carried SCCmec type V. These organisms caused invasive infections such as peritonitis, osteomyelitis, and septic arthritis. Pulsed-field gel electrophoresis analyses showed most (83%, 5/6) isolates carrying mecA were pulsotype D with high similarity (93.8%).
CONCLUSIONS: The findings suggest oxacillin-resistant S. lugdunensis carrying SCCmec type V is emerging in central Taiwan.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  SCCmec gene; Staphylococcus lugdunensis; coagulase-negative staphylococcus; oxacillin resistance

Mesh:

Substances:

Year:  2014        PMID: 25648670     DOI: 10.1016/j.jmii.2014.11.018

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

1.  Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.

Authors:  Lior Nesher; Jeffery Tarrand; Roy F Chemaly; Kenneth Vi Rolston
Journal:  Support Care Cancer       Date:  2016-11-24       Impact factor: 3.603

2.  An lnu(A)-Carrying Multi-Resistance Plasmid Derived from Sequence Type 3 Methicillin-Resistant Staphylococcus lugdunensis May Contribute to Antimicrobial Resistance in Staphylococci.

Authors:  Shih-Cheng Chang; Lee-Chung Lin; Jang-Jih Lu
Journal:  Antimicrob Agents Chemother       Date:  2022-07-25       Impact factor: 5.938

3.  Comparative genomic analysis of Staphylococcus lugdunensis shows a closed pan-genome and multiple barriers to horizontal gene transfer.

Authors:  Xavier Argemi; Dorota Matelska; Krzysztof Ginalski; Philippe Riegel; Yves Hansmann; Jochen Bloom; Martine Pestel-Caron; Sandrine Dahyot; Jérémie Lebeurre; Gilles Prévost
Journal:  BMC Genomics       Date:  2018-08-20       Impact factor: 3.969

4.  Molecular Epidemiological Survey of Staphylococcus lugdunensis Isolates With Variable Number of Repeats in the von Willebrand Factor-Binding Protein Gene.

Authors:  Lee-Chung Lin; Chun-Wen Cheng; Shih-Cheng Chang; Jang-Jih Lu
Journal:  Front Cell Infect Microbiol       Date:  2021-11-11       Impact factor: 5.293

5.  Antimicrobial Resistance and Antimicrobial Activity of Staphylococcus lugdunensis Obtained from Two Spanish Hospitals.

Authors:  Rosa Fernández-Fernández; Carmen Lozano; Laura Ruiz-Ripa; Beatriz Robredo; José Manuel Azcona-Gutiérrez; Carla Andrea Alonso; Carmen Aspiroz; Myriam Zarazaga; Carmen Torres
Journal:  Microorganisms       Date:  2022-07-22

6.  Identification of New Drug Target in Staphylococcus lugdunensis by Subtractive Genomics Analysis and Their Inhibitors through Molecular Docking and Molecular Dynamic Simulation Studies.

Authors:  Yahya Alhamhoom; Umme Hani; Fatima Ezzahra Bennani; Noor Rahman; Md Abdur Rashid; Muhammad Naseer Abbas; Luca Rastrelli
Journal:  Bioengineering (Basel)       Date:  2022-09-07

7.  Molecular Characteristics of Disease-Causing and Commensal Staphylococcus lugdunensis Isolates from 2003 to 2013 at a Tertiary Hospital in Taiwan.

Authors:  Chun-Fu Yeh; Tsui-Ping Liu; Chun-Wen Cheng; Shih-Cheng Chang; Ming-Hsun Lee; Jang-Jih Lu
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.